Ruying Wu1
Hongyang Gong2*- 1Department of Surgery 3, Hebei Provincial First Veterans Hospital (Hebei General Hospital for Veterans), Xingtai, Hebei, China
- 2Department of Physiology, College of Medicine, Chosun University, Gwangju, Republic of Korea
Background: Numerous studies have indicated a potential correlation between COPD, lipid metabolism, and dietary inflammation. However, the exact mechanisms by which dietary inflammation regulates the pathological processes of COPD related to lipid metabolism remain unclear. NHHR is a novel composite index of atherosclerotic lipid profiles, while the Dietary Inflammatory Index (DII) measures diet-induced inflammation. This study explores the relationship between NHHR and COPD and evaluates whether DII mediates this association.
Methods: We employed multivariable logistic regression, smooth curve fitting, threshold effect analysis, and subgroup analysis to explore the relationship between NHHR and the incidence of COPD. Additionally, we conducted a mediation analysis to explore the potential relationship between dietary inflammatory index (DII) levels and the relationship between NHHR and COPD.
Results: This analysis encompassed 13,452 participants, with 2,332 reporting incidents of COPD. Following adjustment for all covariates using multivariable logistic regression, each unit increase in NHHR level and DII level was associated with a 10% (OR = 1.10, 95% CI: 1.05, 1.16) and 8% (OR = 1.08, 95% CI: 1.04, 1.13) increase, respectively, in the incidence rate of COPD. Furthermore, compared to the lowest quartile, the highest quartile of NHHR level and DII level was associated with a 47% (p < 0.001) and 50% (p < 0.001) increase, respectively, in the incidence rate of COPD. Smooth curve fitting and threshold effect analysis revealed a nonlinear relationship between NHHR and the risk of COPD, with a breakpoint at 2.60. Mediation analysis indicated that DII mediated 7.24% of the association between NHHR and COPD (p = 0.004).
Conclusion: Higher NHHR levels are associated with an increased prevalence of COPD. Moreover, this association is mediated by DII, suggesting that an anti-inflammatory diet may be beneficial.
Introduction
COPD is a common chronic airway disorder characterized by persistent airflow limitation and associated respiratory symptoms. Clinical manifestations include chronic cough, sputum production, and progressively worsening dyspnea (1, 2). COPD has become an increasingly significant cause of morbidity, disability, and mortality globally, posing a severe threat to human health. Reports indicate that over 3 million people die from COPD annually worldwide (3), imposing a substantial burden on global public health. Therefore, the identification and management of modifiable risk factors are paramount in preventing or delaying the onset of COPD and reducing its associated complications.
Observational studies suggest that patients with hyperlipidemia are 1.48 times more likely to develop COPD compared to participants without hyperlipidemia (HR = 1.48, 95% CI: 1.44–1.53, p < 0.001) (4), yet the specific mechanisms remain uncertain. Furthermore, research indicates that alterations in lipid metabolism can lead to the production of inflammatory mediators, thereby contributing to the onset and progression of COPD (5). The ratio of non-high-density lipoprotein cholesterol (non-HDL-C) to high-density lipoprotein cholesterol (HDL-C) (NHHR) is a novel composite index for assessing the lipid profile that causes atherosclerosis (6), providing comprehensive insights into anti-atherogenic and atherogenic lipid particles (7). Previous studies have shown that NHHR is associated with many chronic diseases, such as diabetes (8), fatty liver (9), and kidney disease (10). Researcher Zhang et al. (11) and colleagues showed, based on a nationwide study of a large sample of 8,180 individuals aged 20–64 years, that DII levels were significantly and positively associated with Triglycerides, Waist circumference, and BMI levels, with beta and 95% CIs of 2.795 (1.003, 4.588), 0.881 (0.677, 1.084), and 0.318 (0.232, 0.405), respectively. And DII level was significantly negatively correlated with HDL-C level (beta = −0.803, 95%CI: −0.986, −0.621). Another cross-sectional study in adolescents aged 12–18 years (12) showed that DII levels were significantly and positively correlated with LDL-C levels (beta = 4.84, 95%CI: 0.05, 9.62), whereas they were positively but non-significantly correlated with Cholesterol, Triglycerides, and Waist circumference. In addition, dietary factors play an important role in modulating chronic inflammation (13, 14).
In summary, we hypothesize that the relationship between NHHR levels and the odds of developing COPD may be mediated by dietary inflammation. Moreover, pro-inflammatory dietary habits (DII score ≥ 0) have been associated with an increased risk of COPD and declining lung function (15, 16). Findings from a nationally representative study in the United States (17) demonstrate a significant positive correlation between higher DII scores and increased risk of COPD. Consequently, we speculate that dietary inflammation might contribute to the link between NHHR and COPD.
Methods
Study participants
The National Health and Nutrition Examination Survey (NHANES) is a continuous, stratified, multistage sampling program designed to assess the health and nutritional status of both adults and children in the United States, covering a wide range of health and nutrition measures. The NHANES research project has obtained approval from the Research Ethics Review Board of the National Center for Health Statistics (NCHS), and all participants have provided written informed consent (18).
Among the 70,190 participants across seven NHANES cycles from 2005 to 2018, there were 39,749 participants aged 20 years and older. After excluding participants with missing NHHR indicator data, missing DII data (n = 10,299), and missing COPD indicator data (n = 15,998) from the total of 39,749 participants, a final cohort of 13,452 participants was included in the study (Supplementary Figure S1).
Definition of NHHR and DII
The independent variable in this study is NHHR, which, according to previous research (19), is defined as the ratio of Non- High-density lipoprotein cholesterol to High-density lipoprotein cholesterol. Non- High-density lipoprotein cholesterol is calculated as the total cholesterol minus High-density lipoprotein cholesterol.
The Dietary Inflammatory Index (DII) is a key indicator used to evaluate the inflammatory potential of a wide range of dietary components, spanning from vitamins to minerals (20). A DII score of ≥0 signifies a pro-inflammatory diet, whereas a DII score of <0 indicates an anti-inflammatory diet. Additionally, higher DII scores signify unhealthy dietary patterns, whereas lower DII scores denote healthier dietary patterns. The specific algorithm for calculating the DII score is provided in Supplementary material.
Definition of COPD
According to previous studies (21, 22), COPD is defined as meeting one of the following criteria: (1) Post-bronchodilator FEV1/FVC < 0.7; (2) Self-reported emphysema or COPD; (3) Participants aged over 40 years with chronic bronchitis or a smoking history, who were also prescribed COPD medications such as mast cell stabilizers, leukotriene modifiers, inhaled corticosteroids, and selective phosphodiesterase-4 inhibitors.
Covariables
According to previous studies (21, 22), the study covariates include age, gender, ethnicity, Married or not, education level, poverty status, obesity, smoking status, alcohol consumption, and sleep disorders. Additionally, the Charlson Comorbidity Index (CCI) was employed to evaluate participants’ health status and mitigate multicollinearity among comorbidities (23). For detailed information regarding these covariates, please refer to Supplementary Tables S1, S2.
Statistical analysis
Sampling weights were utilized in all statistical analyses to ensure the estimated data’s national representativeness. In our study, “WTMEC2YR” was employed as the weighting variable, with the new weights (2005–2018) calculated as 1/7 × WTMEC2YR. Continuous variables are expressed as mean ± standard deviation (SD), and categorical variables are presented as frequencies (percentages) (24). Weighted t-tests were performed for continuous variables, and weighted chi-square tests were conducted for categorical variables to evaluate differences between the Non-COPD and COPD groups. Weighted multivariable logistic regression was used to evaluate the relationship between NHHR, DII, and COPD. Weighted linear regression was utilized to assess the relationship between NHHR and DII. To control for confounding factors, we adjusted for the following factors in the regression models (Model 1 was unadjusted for any potential confounders. Model 2 was adjusted for age, gender, race, Married or not, education level, and poverty status; Model 3 further adjusted for sleep disorders, obesity, smoking status, alcohol consumption status, and CCI). Results are presented as odds ratios (ORs) or β coefficients with their respective 95% confidence intervals (95% CIs). Additionally, subgroup analyses were conducted to explore potential relationships between NHHR and COPD across various subgroups. Restricted cubic splines (RCS) and segmented linear regression models were used to investigate potential nonlinear association and threshold effects between NHHR and COPD (25). To examine whether the effect of NHHR (X) on COPD (Y) occurrence was mediated by DII (M), mediation analysis was performed based on the precondition of “statistically significant association between X and M” and “statistically significant association between M and Y” (26).
Several sensitivity analyses were performed in this study to verify the robustness of the results. First, Multiple imputation by chained equations (MICE) and repeated the main analyses (27). We used multiple imputations, based on 5 imputed data sets to calculate missing NHHR, DII, and COPD data. In addition, we excluded subjects with asthma for further analyses. Finally, to further control for confounders, we further adjusted for Triglycerides, LDL-C, HDL-C, LDL-C, and glycohemoglobin. We used the vif() function from the “car “package to test for multicollinearity in the covariates, with a variance inflation factor (VIF) < 10 indicating the absence of multicollinearity (28). In the present study, all the VIFs were less than 2. The mediation effect was determined using the “mediation” package in R software (29). All data analyses were conducted in R software (version 4.3.1), utilizing the “survey” and “ggplot2” packages for weighted data analysis, restricted cubic spline functions, and visualization. A two-sided p-value <0.05 was considered statistically significant (30).
Results
Baseline characteristics
In this study, a total of 13,452 participants aged 20 years or older were included, representing approximately 80.01 million US adults. The mean (SD) NHHR value was 2.85 (1.46), and the prevalence of COPD was 17.34% (equivalent to 13.85 million individuals). Additionally, both NHHR and DII levels were higher in the COPD group compared to the Non-COPD group. Preliminary assessment revealed that individuals in the COPD group were characterized by older age, female gender, White race, married status, higher socioeconomic status, obesity, smoking, alcohol consumption, higher CCI, and higher DII scores compared to those in the non-COPD group. For specific details, please refer to Table 1.
Table 1. Baseline characteristics of participants with or without COPD.
The association between NHHR and COPD
As shown in Table 2, three different models were employed to assess the association between NHHR and COPD. In model 3 adjusting for all covariates, for every 1 standard deviation increase in NHHR, there was a 10% increase in the odds of COPD [1.10 (1.05, 1.16)]. Furthermore, compared to the first quartile (Q1) of NHHR, the odds of COPD increased by 47% in the fourth quartile (Q4) [1.47 (1.19, 1.81)] in the model 3. Additionally, as NHHR increases from Q1 to Q4, the OR values also gradually increase, with a P for trend less than 0.001. Models 1 and 2 also demonstrate consistency in the results.
Table 2. Association between NHHR, DII, and COPD.
The RCS results (Figure 1) revealed a J-shaped nonlinear association between NHHR and COPD, with an inflection point at 2.60 (P for non-linear = 0.017). Threshold effect analysis indicated that when NHHR levels were below 2.60, there was no significant association between NHHR and COPD [OR = 1.05, 95% CI: 0.81, 1.36]. However, when NHHR levels exceeded 2.60, there was a significant positive relationship between NHHR and COPD [OR = 1.09(1.02, 1.16)] (Table 3). Subgroup analysis demonstrated that the correlation between NHHR and COPD risk remained robust across all subgroups (Figure 2).
Figure 1. Restricted cubic spline curves for the association between the NHHR and COPD. Adjusted for age, gender, education level, marital, PIR, race, obesity, smoking, drinking, sleep disorder, and CCI. NHHR, Non-high-density lipoprotein cholesterol (non-HDL-C) to high-density lipoprotein cholesterol (HDL-C) ratio; COPD, Chronic obstructive pulmonary disease; CCI, Charlson Comorbidity Index; PIR, Ratio of family income to poverty.
Table 3. Threshold effect analysis of NHHR on COPD using the two-piecewise linear regression model.
Figure 2. Subgroup analysis for the association between NHHR and COPD. OR was calculated as each standard deviation increase in NHHR. Adjusted for age, gender, education level, marital, PIR, race, obesity, smoking, drinking, sleep disorder, and CCI. NHHR, Non-high-density lipoprotein cholesterol (non-HDL-C) to high-density lipoprotein cholesterol (HDL-C) ratio; COPD, Chronic obstructive pulmonary disease; CCI, Charlson Comorbidity Index; PIR, Ratio of family income to poverty.
DII and risk of COPD
Table 2 displays the association between DII and COPD. In model 3, Following adjustment for all covariates, compared to the first quartile (Q1) of DII, the odds of COPD increased by 50% in the fourth quartile (Q4) [OR = 1.50 (1.19, 1.89)]. When DII was considered as a continuous variable, the positive relationship between DII and COPD remained statistically significant (OR = 1.08, 95% CI: 1.04, 1.13). Models 1 and 2 also demonstrate consistency in the results. Additionally, the RCS results (Supplementary Figure S2) revealed a significant linear association between DII and COPD.
Association of NHHR and DII
Following adjustment for all covariates, there was a significant statistical association between NHHR and DII (β = 0.10, 95% CI: 0.07, 0.12, p < 0.001) (Supplementary Table S3).
Mediation effect
Based on the above analysis, our study meets the prerequisites for conducting mediation analysis. Following adjustment for all covariates, we observed the mediation effect of DII (Figure 3). DII (indirect effect = 7.26*10−4, p = 0.004; direct effect = 9.21*10−3, p < 0.001) mediated 7.24% (mediation proportion = indirect effect/(indirect effect + direct effect) *100%, p = 0.004) of the association between NHHR and COPD risk. Therefore, DII can be considered a mediating factor in the relationship between NHHR and the odds of COPD.
Figure 3. Mediation analysis. IE, indirect effect; DE, direct effect; NHHR, Non-high-density lipoprotein cholesterol (non-HDL-C) to high-density lipoprotein cholesterol (HDL-C) ratio; COPD, Chronic obstructive pulmonary disease; DII, dietary inflammatory index.
Sensitivity analysis
To ensure the stability of the results, this study performed multiple interpolations of missing data for NHHR, DII, and COPD, which remained consistent with the primary results (Supplementary Tables S4, S5). In addition, the results remained robust after excluding participants with asthma (Supplementary Tables S6, S7). After further adjustments for Triglycerides, LDL-C, HDL-C, LDL-C, and Glycohemoglobin, the results remained stable (Supplementary Table S8).
Discussion
This study provides new insights into the mediating role of DII in the association between NHHR and COPD. Our results indicate that participants with elevated NHHR and DII are at increased risk of COPD. Additionally, it is noteworthy that we identified a J-shaped association between NHHR and COPD, with a turning point at 2.60. These findings suggest that NHHR could potentially function as a predictive factor for COPD development, and anti-inflammatory diets may mitigate the impact of NHHR on COPD risk.
In recent years, there has been increasing scholarly attention to the role of inflammatory dietary patterns in the progression of COPD. In a cross-sectional study based on a national survey involving 9,929 American participants, 5.69% of individuals were diagnosed with COPD, and high DII levels were identified as an independent risk factor for COPD (17). Similarly, in our study, we observed similar results, indicating a positive correlation between DII and the occurrence of COPD. Furthermore, findings from a study involving 4,267 Korean men aged over 40 also demonstrated that DII was significantly associated with lung function and COPD (31). Promoting a healthy diet with anti-inflammatory properties may help prevent chronic obstructive pulmonary disease in adult men. Our study once again highlights the potential role of DII in COPD.
An increasing body of research indicates that NHHR can predict the risk of most lipid-related diseases (32, 33). Although direct studies on the connection between COPD and lipid metabolism are relatively scarce at present, most studies have shown a potential relationship between COPD and various lipid-related factors. For instance, a prospective cohort study with a 5-year follow-up found that for every 100 mg increase in triglyceride levels, the mortality rate of COPD patients increased by 42% (HR: 1.42, 95% CI: 1.06–1.89) (34). Additionally, a retrospective cohort study conducted in Taiwan, spanning over a decade, included 21,790 patients with hyperlipidemia and 87,160 patients without hyperlipidemia. It found that the risk of COPD occurrence was 1.48 times higher among patients with hyperlipidemia compared to those without (95% CI, 1.44, 1.53) (4). These findings indirectly support a positive correlation between NHHR levels and COPD occurrence, further aiding researchers in exploring the potential associations between lipid profiles, such as NHHR, and COPD incidence.
This study indicates that low levels of DII scores (representing a healthy diet) may mitigate the relationship between NHHR and the likelihood of COPD. Research by Fekete et al. (35) suggests that COPD patients often have inadequate intake of omega-3 polyunsaturated fatty acids (PUFAs), which have anti-inflammatory properties and can lower cholesterol and triglyceride levels. Our study corroborates this viewpoint. On the other hand, higher DII levels are associated with elevated total cholesterol (TC) and LDL-C levels (36), and lipid metabolism disorders exacerbate the occurrence and progression of COPD (37). Thus, our study findings are further supported: an anti-inflammatory dietary pattern (i.e., lower DII scores) helps alleviate the relationship between NHHR and the likelihood of COPD.
This study found a potential link between DII and the relationship between NHHR and COPD. Firstly, the interaction between inflammation and lipid metabolism is notable. COPD is characterized by airflow limitation and chronic airway inflammation. Inflammation is prevalent in COPD patients and is closely related to lipid metabolism disorders (38). Inflammatory mediators, such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and C-reactive protein (CRP), are not only elevated in the local airways but also in the systemic circulation (39). Moreover, these mediators can affect lipid metabolism through various pathways: (1) Inflammatory mediators promote adipocyte catabolism: TNF-α and IL-6 can induce adipocytes to secrete fatty acids and reduce fat synthesis. This metabolic change leads to increased plasma free fatty acids (FFA), further causing insulin resistance and lipid metabolism disorders (40). (2) Inflammatory mediators influence cholesterol metabolism: During inflammation, the liver synthesizes acute-phase response proteins such as CRP and serum amyloid A (SAA), which bind to high-density lipoprotein (HDL), impairing HDL function and affecting cholesterol transport and reverse cholesterol transport (41). Secondly, lipid metabolism disorders impact lung function. These disorders affect overall health and can directly impact lung function. Specifically: (1) Lipid deposition and airway structural changes: Abnormal lipid deposition in airway smooth muscle and surrounding tissues may lead to airway wall thickening and airflow limitation, exacerbating COPD’s pathological changes (42). (2) Oxidative stress and cellular damage: Elevated plasma FFA and low-density lipoprotein (LDL) can be oxidized to form oxidized LDL (ox-LDL), which induces oxidative stress and apoptosis in lung tissue, further damaging the lungs (43). Lastly, diet regulates inflammation and lipid metabolism. Dietary patterns play a critical role in modulating these processes, and appropriate dietary interventions can alleviate inflammation and lipid metabolism disorders in COPD patients. For example: (1) Anti-inflammatory diet: Foods rich in omega-3 fatty acids (such as fish oil) have anti-inflammatory effects and can reduce the production of inflammatory mediators (44, 45). Additionally, foods rich in polyphenols (such as fruits and vegetables) have significant anti-inflammatory effects (46). (2) Lipid-regulating diet: A low-fat diet rich in fiber and antioxidants can improve lipid metabolism, lower plasma FFA and LDL levels, and help reduce the risk and progression of COPD (47, 48).
Our research possesses the following advantages: (1) NHHR demonstrates its unique predictive accuracy across multiple studies. Additionally, NHHR, characterized by its non-invasiveness, novelty, simplicity, accessibility, and cost-effectiveness, is widely adopted as a clinical predictive factor, bringing extensive developmental prospects to the clinical practice of COPD patients (19). (2) We utilize nationally representative data and consider sample weights, facilitating a comprehensive exploration of the relationship between NHHR in U.S. adults and the likelihood of COPD. (3) To the best of our knowledge, this is the first investigation of the mediating role of DII scores in the association between NHHR and the odds of COPD.
However, our study also has some limitations: (1) While the mediation analysis reflects NHHR’s potential influence on COPD occurrence through DII, extensive prospective cohort studies, randomized controlled trials, or animal experiments are still needed in the future to establish conclusive pathogenic mechanisms. (2) Despite including a relatively large number of covariates based on previous research to enhance the robustness of our study results, limitations of the NHANES database prevent us from eliminating all potential confounding factors’ ultimate impact on the study results. Therefore, the results of this study should be interpreted cautiously and objectively. (3) The use of 24-h dietary recall and COPD-related questionnaires may introduce bias into the results, as they may not accurately reflect participants’ long-term or typical dietary indicators and COPD diagnosis.
Conclusion
In conclusion, higher NHHR levels increase the risk of COPD, while lower DII levels may mitigate this relationship. Therefore, controlling NHHR levels and adhering to anti-inflammatory diets are of significant clinical value in reducing the risk of COPD.
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary material.
Ethics statement
The studies involving humans were approved by the Research Ethics Review Board of the National Center for Health Statistics (NCHS). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
RW: Conceptualization, Data curation, Investigation, Methodology, Writing – original draft. HG: Conceptualization, Data curation, Software, Supervision, Validation, Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Acknowledgments
We are deeply grateful for the provision of all data by the NHANES database.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2024.1427586/full#supplementary-material
Abbreviations
DII, Dietary inflammatory index; COPD, Chronic obstructive pulmonary disease; TC, Total cholesterol; TG, Triglyceride; WC, Waist circumference; BMI, Body mass index; NHHR, Non-high-density lipoprotein cholesterol (Non-HDL-C) to high-density lipoprotein cholesterol (HDL-C) ratio; LDL-C, Low-density lipoprotein cholesterol; HDL-C, High-density lipoprotein cholesterol; NHANES, National Health and Nutrition Examination Survey.
References
1. Agustí, A, Celli, BR, Criner, GJ, Halpin, D, Anzueto, A, Barnes, P, et al. Report: GOLD executive summary. Arch Bronconeumol. (2023) 59:232–48. doi: 10.1016/j.arbres.2023.02.009
2. Kotlyarov, S. High-density lipoproteins: a role in inflammation in COPD. Int J Mol Sci. (2022) 23:8128. doi: 10.3390/ijms23158128
3. Rabe, KF, and Watz, H. Chronic obstructive pulmonary disease. Lancet. (2017) 389:1931–40. doi: 10.1016/S0140-6736(17)31222-9
4. Yang, H-Y, Hu, L-Y, Chen, H-J, Chen, R-Y, Hu, C-K, and Shen, C-C. Increased risk of chronic obstructive pulmonary disease in patients with hyperlipidemia: a Nationwide population-based cohort study. Int J Environ Res Public Health. (2022) 19:12331. doi: 10.3390/ijerph191912331
5. Chen, H, Li, Z, Dong, L, Wu, Y, Shen, H, and Chen, Z. Lipid metabolism in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. (2019) 14:1009–18. doi: 10.2147/COPD.S196210
6. Chen, T, Cheng, Y, Song, Z, Zhang, G, Zeng, T, and Chao, H. Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and kidney stone: evidence from NHANES 2007–2018. BMC Public Health. (2024) 24:1818. doi: 10.1186/s12889-024-19265-4
7. He, R, Ye, Y, Zhu, Q, and Xie, C. Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia in individuals with cancer: a cross-sectional study. Lipids Health Dis. (2024) 23:217. doi: 10.1186/s12944-024-02205-x
8. Tan, M-Y, Weng, L, Yang, Z-H, Zhu, S-X, Wu, S, and Su, J-H. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with type 2 diabetes mellitus: recent findings from NHANES 2007-2018. Lipids Health Dis. (2024) 23:151. doi: 10.1186/s12944-024-02143-8
9. Wang, K, Shan, S, Zheng, H, Zhao, X, Chen, C, and Liu, C. Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study. Lipids Health Dis. (2018) 17:196. doi: 10.1186/s12944-018-0848-8
10. Du, Y-Z, Dong, Q-X, Hu, H-J, Guo, B, Li, Y-H, Zhang, J, et al. A cross-sectional analysis of the relationship between the non-high density to high density lipoprotein cholesterol ratio (NHHR) and kidney stone risk in American adults. Lipids Health Dis. (2024) 23:158. doi: 10.1186/s12944-024-02150-9
11. Zhang, X, Guo, Y, Yao, N, Wang, L, Sun, M, Xu, X, et al. Association between dietary inflammatory index and metabolic syndrome: analysis of the NHANES 2005-2016. Front Nutr. (2022) 9:991907. doi: 10.3389/fnut.2022.991907
12. Sethna, CB, Alanko, D, Wirth, MD, Shivappa, N, Hebert, JR, Khan, S, et al. Dietary inflammation and cardiometabolic health in adolescents. Pediatr Obes. (2021) 16:e12706. doi: 10.1111/ijpo.12706
13. Cavicchia, PP, Steck, SE, Hurley, TG, Hussey, JR, Ma, Y, Ockene, IS, et al. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr. (2009) 139:2365–72. doi: 10.3945/jn.109.114025
14. Giugliano, D, Ceriello, A, and Esposito, K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. (2006) 48:677–85. doi: 10.1016/j.jacc.2006.03.052
15. Chen, C, Yang, T, and Wang, C. The dietary inflammatory index and early COPD: results from the National Health and nutrition examination survey. Nutrients. (2022) 14:2841. doi: 10.3390/nu14142841
16. Wang, S, Wang, Y, Hu, X, and Lu, L. Association between dietary inflammation index and asthma COPD overlap. Sci Rep. (2024) 14:8077. doi: 10.1038/s41598-024-58813-1
17. Liu, H, Tan, X, Liu, Z, Ma, X, Zheng, Y, Zhu, B, et al. Association between diet-related inflammation and COPD: findings from NHANES III. Front Nutr. (2021) 8:732099. doi: 10.3389/fnut.2021.732099
18. NHANES - NCHS Research Ethics Review Board Approval. (2022). Available at: https://www.cdc.gov/nchs/nhanes/irba98.htm (Accessed April 23, 2024).
19. Qing, G, Deng, W, Zhou, Y, Zheng, L, Wang, Y, and Wei, B. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and suicidal ideation in adults: a population-based study in the United States. Lipids Health Dis. (2024) 23:17. doi: 10.1186/s12944-024-02012-4
20. Wan, H, Zhang, Y, Ning, Z, Liu, M, and Yang, S. Associations of cereal fiber intake with rheumatoid arthritis mediated by dietary inflammatory index: insights from NHANES 2011–2020. Sci Rep. (2024) 14:2415. doi: 10.1038/s41598-024-52806-w
21. Liu, Z, Li, J, Chen, T, Zhao, X, Chen, Q, Xiao, L, et al. Association between dietary antioxidant levels and chronic obstructive pulmonary disease: a mediation analysis of inflammatory factors. Front Immunol. (2024) 14:1310399. doi: 10.3389/fimmu.2023.1310399
22. Li, W-W, Ren, K-L, Yu, J, Guo, H-S, Liu, B-H, and Sun, Y. Association of dietary niacin intake with the prevalence and incidence of chronic obstructive pulmonary disease. Sci Rep. (2024) 14:2863. doi: 10.1038/s41598-024-53387-4
23. Jiang, S, Wang, Y, Wang, M, Xu, Y, Zhang, W, Zhou, X, et al. Sex difference in the non-linear relationship between ethylene oxide exposure and depressive symptoms: a cross-sectional study. J Affect Disord. (2024) 345:386–93. doi: 10.1016/j.jad.2023.10.147
24. Lu, Y, Lu, L, Zhang, G, Zhang, W, Cheng, Y, and Tong, M. Serum 25-hydroxyvitamin D mediates the association between heavy metal exposure and cardiovascular disease. BMC Public Health. (2024) 24:542. doi: 10.1186/s12889-024-18058-z
25. Tang, S, Luo, S, Wu, Z, and Su, J. Association between blood heavy metal exposure levels and risk of metabolic dysfunction associated fatty liver disease in adults: 2015–2020 NHANES large cross-sectional study. Front Public Health. (2024) 12:1280163. doi: 10.3389/fpubh.2024.1280163
26. Hu, Z, Li, Y, Yang, Y, Yu, W, Xie, W, Song, G, et al. Serum lipids mediate the relationship of multiple polyaromatic hydrocarbons on non-alcoholic fatty liver disease: a population-based study. Sci Total Environ. (2021) 780:146563. doi: 10.1016/j.scitotenv.2021.146563
27. Lu, Y, Zhang, J, Li, H, and Li, T. Association of non-alcoholic fatty liver disease with self-reported osteoarthritis among the US adults. Arthritis Res Ther. (2024) 26:40. doi: 10.1186/s13075-024-03272-2
28. Li, Z, Liu, B, Tong, X, Ma, Y, Bao, T, Yue, J, et al. The association between sarcopenia and incident of depressive symptoms: a prospective cohort study. BMC Geriatr. (2024) 24:74. doi: 10.1186/s12877-023-04653-z
29. Wu, Y, Tan, Z, Zhen, J, Liu, C, Zhang, J, Liao, F, et al. Association between diet soft drink consumption and metabolic dysfunction-associated steatotic liver disease: findings from the NHANES. BMC Public Health. (2023) 23:2286. doi: 10.1186/s12889-023-17223-0
30. Chen, S, Luo, M, Sheng, Z, Zhou, R, Xiang, W, Huang, W, et al. Association of lipid accumulation product with all-cause and cardiovascular disease mortality: result from NHANES database. Nutr Metab Cardiovasc Dis. (2023) 34:1467–76. doi: 10.1016/j.numecd.2023.10.015
31. Kim, J-A, and Lee, S-Y. Association between chronic obsructive pulmonary disease and dietary inflammatory index in Korean men over 40s-based on the 2016-2019 Korea National Health and nutrition examination survey. Korean J Health Promot. (2023) 23:182–9. doi: 10.15384/kjhp.2023.23.4.182
32. Yang, S, Zhong, J, Ye, M, Miao, L, Lu, G, Xu, C, et al. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. Lipids Health Dis. (2020) 19:242. doi: 10.1186/s12944-020-01421-5
33. Iannuzzi, A, Giallauria, F, Gentile, M, Rubba, P, Covetti, G, Bresciani, A, et al. Association between non-HDL-C/HDL-C ratio and carotid intima-media thickness in post-menopausal women. J Clin Med. (2021) 11:78. doi: 10.3390/jcm11010078
34. Tanni, S, Zamuner, A, Schelini, K, Coelho, L, Caram, L, Vale, S, et al. Triglycerides are associated with five-year mortality in COPD patients. Eur Respir J. (2012) 40.
35. Fekete, M, Szarvas, Z, Fazekas-Pongor, V, Lehoczki, A, Tarantini, S, and Varga, JT. Effects of omega-3 supplementation on quality of life, nutritional status, inflammatory parameters, lipid profile, exercise tolerance and inhaled medications in chronic obstructive pulmonary disease. Ann Pall Med. (2022) 11:2819–2812829. doi: 10.21037/apm-22-254
36. Vajdi, M, Farhangi, MA, and Mahmoudi-Nezhad, M. Dietary inflammatory index significantly affects lipids profile among adults: an updated systematic review and meta-analysis. Int J Vitam Nutr Res. (2022) 92:431–47. doi: 10.1024/0300-9831/a000688
37. Kotlyarov, S, and Kotlyarova, A. Molecular mechanisms of lipid metabolism disorders in infectious exacerbations of chronic obstructive pulmonary disease. Int J Mol Sci. (2021) 22:7634. doi: 10.3390/ijms22147634
38. Emami Ardestani, M, and Zaerin, O. Role of serum interleukin 6, albumin and C-reactive protein in COPD patients. Tanaffos. (2015) 14:134–40.
39. Yanbaeva, DG, Dentener, MA, Creutzberg, EC, and Wouters, EFM. Systemic inflammation in COPD: is genetic susceptibility a key factor? COPD: J Chron Obstruct Pulmon Dis. (2006) 3:51–61. doi: 10.1080/15412550500493436
40. Górecka, M, Krzemiński, K, Mikulski, T, and Ziemba, AW. ANGPTL4, IL-6 and TNF-α as regulators of lipid metabolism during a marathon run. Sci Rep. (2022) 12:19940. doi: 10.1038/s41598-022-17439-x
41. Webb, NR. High-density lipoproteins and serum amyloid a (SAA). Curr Atheroscler Rep. (2021) 23:7. doi: 10.1007/s11883-020-00901-4
42. Higham, A, Quinn, AM, Cançado, JED, and Singh, D. The pathology of small airways disease in COPD: historical aspects and future directions. Respir Res. (2019) 20:49. doi: 10.1186/s12931-019-1017-y
43. Shen, Y, Yang, T, Guo, S, Li, X, Chen, L, Wang, T, et al. Increased serum ox-LDL levels correlated with lung function, inflammation, and oxidative stress in COPD. Mediat Inflamm. (2013) 2013:972347. doi: 10.1155/2013/972347
44. Yu, H, Su, X, Lei, T, Zhang, C, Zhang, M, Wang, Y, et al. Effect of Omega-3 fatty acids on chronic obstructive pulmonary disease: a systematic review and Meta-analysis of randomized controlled trials. Int J Chron Obstruct Pulmon Dis. (2021) 16:2677–86. doi: 10.2147/COPD.S331154
45. Zailani, H, Satyanarayanan, SK, Liao, W-C, Hsu, Y-T, Huang, S-Y, Gałecki, P, et al. Roles of Omega-3 polyunsaturated fatty acids in managing cognitive impairment in chronic obstructive pulmonary disease: a review. Nutrients. (2023) 15:4363. doi: 10.3390/nu15204363
46. Rudrapal, M, Khairnar, SJ, Khan, J, Dukhyil, AB, Ansari, MA, Alomary, MN, et al. Dietary polyphenols and their role in oxidative stress-induced human diseases: insights into protective effects, antioxidant potentials and mechanism(s) of action. Front Pharmacol. (2022) 13:806470. doi: 10.3389/fphar.2022.806470
47. Seyedrezazadeh, E, Moghaddam, MP, Ansarin, K, Asghari Jafarabadi, M, Sharifi, A, Sharma, S, et al. Dietary factors and risk of chronic obstructive pulmonary disease: a systemic review and meta-analysis. Tanaffos. (2019) 18:294–309.
Keywords: NHHR, DII, COPD, NHANES, mediation analysis
Citation: Wu R and Gong H (2024) The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and chronic obstructive pulmonary disease: the mediating role of dietary inflammatory index. Front. Nutr. 11:1427586. doi: 10.3389/fnut.2024.1427586
Edited by:
Olga Pivovarova-Ramich, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), GermanyReviewed by:
Yang Zou, Jiangxi Provincial People’s Hospital, ChinaErica Bazzan, University Hospital of Padua, Italy
Fedor Malykhin, Stavropol State Medical University, Russia
Copyright © 2024 Wu and Gong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hongyang Gong, aHlnb25nQGNob3N1bi5hYy5rcg==